AI Verdict
REGN has stronger fundamentals based on our AI analysis.
EW vs REGN Fundamental Comparison
| Metric | EW | REGN |
|---|---|---|
| Revenue | $1.6B | $3.6B |
| Net Income | $380.7M | $727.2M |
| Net Margin | 23.1% | 20.2% |
| ROE | 3.7% | 2.3% |
| ROA | 2.9% | 1.8% |
| Current Ratio | 4.42x | 3.57x |
| Debt/Equity | 0.06x | 0.06x |
| EPS | $0.66 | $6.75 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
EW vs REGN: Frequently Asked Questions
Is EW or REGN the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), REGN has stronger fundamentals. EW is graded C (76% confidence) while REGN is graded A (80% confidence). This is not investment advice.
How does EW compare to REGN fundamentally?
Edwards Lifesciences Corp has ROE of 3.7% vs REGENERON PHARMACEUTICALS, INC.'s 2.3%. Net margins are 23.1% vs 20.2% respectively.
Which stock pays higher dividends, EW or REGN?
EW has a dividend yield of N/A or no dividend while REGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in EW or REGN for long term?
For long-term investing, consider that EW has a C grade with 76% confidence, while REGN has a A grade with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about EW vs REGN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EW vs REGN, the AI consensus favors REGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.